Early Detection of Lung Cancer Shows Promise in Liquid Biopsy Study

While treating cancer in its earliest stages dramatically increases overall survival rates, the detection of carcinogenesis in these preliminary stages has proven difficult. However now, investigators at the Dana-Farber Cancer Institute have just presented findings from the ongoing Circulating Cell-Free Genome Atlas (CCGA) study suggesting that a liquid biopsy test analyzing free-floating DNA in the blood may be able to detect early-stage lung cancer.The data will be presented today at the 2018